Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Deborah Paschal

Deborah Paschal

Jefferson Aria Health, USA

Title: The impact of discharge planning for the hospitalized hyperglycemic patient

Biography

Biography: Deborah Paschal

Abstract

Discharge of the hyperglycemic patient from inpatient care is associated with increased risk for all patients and particularly for those with a history of diabetes or new-onset hyperglycemia. Continuity of care is considered essential at the time of discharge by the American Association of Clinical Endocrinologists (AACE) and the ADA. Current recommendations suggest that
planning for discharge to outpatient settings should begin at the time of hospital admission, with plans updated to refl ect changes in anticipated patient needs, patient home environment and support. At the time of discharge, there may be risk of continuation of anti-hyperglycemic therapy, initiated to cover medical stress, in doses that will subsequently be unsafe. In the face of this complexity,
educational programs alone will not suffice to improve care. Institutional commitment and systems changes are essential. As they are readied for hospital release, discharge planning should prepare patients for self-monitoring and self-care at home and give them the survival skills necessary to maintain glycemic control. A treatment plan devised by a multidisciplinary team is the best means to ensure that patients receive a practical and successful treatment regimen that can be readily overseen by themselves, their families, and their post discharge medical team.